Search

Search Results

3 results found. Results per page: [ 20 ] [ 40 ] [ 60 ] [ 80 ] [ 100 ] [ 200 ] [ 300 ]

Sort by: [ Publication Date ] [ Score ]

Direction: [ Desc ] [ Asc ]

Year of publication: [ 2026 ] [ 2025 ] [ 2024 ] [ 2023 ] [ 2022 ] [ 2021 ] [ 2020 ] [ 2019 ] [ 2018 ] [ 2017 ] [ 2016 ] [ 2015 ] [ 2014 ] [ 2013 ] [ 2012 ] [ 2011 ] [ 2010 ] [ 2009 ] [ Any ]

• Research PaperVolume 12, Issue 3pp 2777-2797

  TP53/miR-34a-associated signaling targets SERPINE1 expression in human pancreatic cancer

  Relevance score: 0.00

  Shaw M. Akula, Peter P. Ruvolo, James A. McCubrey

  Keywords: PDAC, Aging, cancer, TP53, miR-34a, SERPINE1

  Published in Aging on January 27, 2020

  Show abstract
• Research PaperVolume 11, Issue 11pp 3679-3703

  Evaluation of the diagnostic ability of laminin gene family for pancreatic ductal adenocarcinoma

  Relevance score: 0.00

  Chengkun Yang, Zhengqian Liu, Xianmin Zeng, Qiongyuan Wu, Xiwen Liao, Xiangkun Wang, Chuangye Han, Tingdong Yu, Guangzhi Zhu, Wei Qin, Tao Peng

  Keywords: PDAC, laminin, CA19-9, prognosis, diagnosis

  Published in Aging on June 10, 2019

  Show abstract
• Research PaperVolume 14, Issue 8pp 3365-3386

  Wild type and gain of function mutant TP53 can regulate the sensitivity of pancreatic cancer cells to chemotherapeutic drugs, EGFR/Ras/Raf/MEK, and PI3K/mTORC1/GSK-3 pathway inhibitors, nutraceuticals and alter metabolic properties

  Relevance score: 0.00

  James A. McCubrey, Akshaya K. Meher, Shaw M. Akula, Stephen L. Abrams, Linda S. Steelman, Michelle M. LaHair, Richard A. Franklin, Alberto M. Martelli, Stefano Ratti, Lucio Cocco, Fulvio Barbaro, Przemysław Duda, Agnieszka Gizak

  Keywords: TP53, targeted therapy, PDAC, chemotherapeutic drugs, metabolic properties

  Published in Aging on April 27, 2022

  Show abstract